Three SV-created biotech companies included in The Times’ ‘100 Tech Ones to Watch’

The Times article 'The great minds turning science into multimillion dollar companies' highlights the three SV-created biotech companies included in The Times’ ‘100 Tech Ones to Watch’ this year.

All three were co-founded by SV Operating Partner Ruth McKernan and are now led by female CEOs – Draig Therapeutics by Ivana Magovcevic-Liebisch, PhD, JD, Alchemab Therapeutics Ltd by Jane Osbourn OBE and AstronauTx, a company co-founded by SV Health Investors' Dementia Discovery Fund (DDF), by Jane Rhodes.

View the article
Investing in Women Code Logo
PROUD SIGNATORIES

We invest in talented innovators. We strongly adhere to the view that diversity, including under-represented groups, strongly adds to success. If you are an entrepreneur seeking investment and a partner who can help you to build your business, we would love to hear from you. Please get in contact with our team.

Privacy PolicyTerms of UseCommitment to the UK Stewardship CodeSV Health Managers LLP Engagement Policy